ADVANCED ENDOMETRIAL CANCER
Clinical trials for ADVANCED ENDOMETRIAL CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED ENDOMETRIAL CANCER trials appear
Sign up with your email to follow new studies for ADVANCED ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New IgE antibody trial targets Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase trial tests a new drug called MOv18 IgE in people with advanced ovarian, endometrial, or triple-negative breast cancers that have a specific marker (folate receptor alpha). The study has two parts: first, finding a safe dose, and then checking how well that dose …
Matched conditions: ADVANCED ENDOMETRIAL CANCER
Phase: PHASE1 • Sponsor: Epsilogen Ltd • Aim: Disease control
Last updated May 26, 2026 12:11 UTC
-
New hope for advanced endometrial cancer: drug combo trial underway
Disease control Recruiting nowThis study tests a drug called envafolimab, given alone or with another drug called lenvatinib, in people with advanced endometrial cancer that has not responded to standard chemotherapy. The goal is to see if the treatment can shrink tumors. About 108 participants will take part…
Matched conditions: ADVANCED ENDOMETRIAL CANCER
Phase: PHASE2 • Sponsor: 3D Medicines (Sichuan) Co., Ltd. • Aim: Disease control
Last updated May 22, 2026 14:03 UTC